Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein
(Q38474705)
scientific article published on May 1997
scientific article published on May 1997
Language:
other details
description | scientific article published on May 1997 |
External Links
(P356) |
10.1002/(SICI)1096-9098(199705)65:1<22::AID-JSO5>3.0.CO;2-Q
|
(P698) |
9179263
|